See also this year's filing and all EDGAR filings for this company.
PDF Report 0001485003_2017_Carisma_Therapeutics_Inc.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001485003, Carisma Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 25,927,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 16,864,000 |
| 2 | PropertyPlantAndEquipmentNet | 796,000 |
| 3 | remainder_Assets | 60,510,000 |
| 4 | LiabilitiesCurrent | 3,980,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,736,000 |
| 9 | ResearchAndDevelopmentExpense | 13,479,000 |
| 10 | remainder_Expenses | -1,095,000 |
| 11 | remainder_Revenues | 406,000 |
| 12 | remainder_NetIncome | 28,605,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 104,097,000 |
| 1 | Liabilities | 3,980,000 |
| 2 | Expenses | 27,120,000 |
| 3 | Revenues | 406,000 |
| 4 | StockholdersEquity | 100,117,000 |
| 5 | NetIncome | 1,891,000 |
| 6 | ComprehensiveNetIncome | 1,891,000 |
| 7 | BaseVar | 82,104,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.07 |
| 9 | EconomicCapitalRatio | 4.45 |